Biogen's total assets for Q1 2025 were $28.03B, a decrease of -0.06% from the previous quarter. BIIB total liabilities were $11.05B for the fiscal quarter, a -2.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.